MX2009011391A - Emulsion oftalmica aceite en agua que contiene prostaglandinas. - Google Patents

Emulsion oftalmica aceite en agua que contiene prostaglandinas.

Info

Publication number
MX2009011391A
MX2009011391A MX2009011391A MX2009011391A MX2009011391A MX 2009011391 A MX2009011391 A MX 2009011391A MX 2009011391 A MX2009011391 A MX 2009011391A MX 2009011391 A MX2009011391 A MX 2009011391A MX 2009011391 A MX2009011391 A MX 2009011391A
Authority
MX
Mexico
Prior art keywords
water emulsions
emulsions containing
ophthalmic oil
containing prostaglandins
prostaglandin
Prior art date
Application number
MX2009011391A
Other languages
English (en)
Spanish (es)
Inventor
Fabio Carli
Baronian Mihran
Rene Schmid
Elisabetta Chiellini
Original Assignee
Azad Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Azad Pharma Ag filed Critical Azad Pharma Ag
Publication of MX2009011391A publication Critical patent/MX2009011391A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2009011391A 2007-04-24 2008-04-24 Emulsion oftalmica aceite en agua que contiene prostaglandinas. MX2009011391A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07008357A EP1985298A1 (en) 2007-04-24 2007-04-24 Ophtalmic oil-in-water emulsions containing prostaglandins
US94269107P 2007-06-08 2007-06-08
PCT/EP2008/003317 WO2008128779A1 (en) 2007-04-24 2008-04-24 Ophthalmic oil-in-water emulsions containing prostaglandins

Publications (1)

Publication Number Publication Date
MX2009011391A true MX2009011391A (es) 2010-02-09

Family

ID=38924841

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009011391A MX2009011391A (es) 2007-04-24 2008-04-24 Emulsion oftalmica aceite en agua que contiene prostaglandinas.

Country Status (11)

Country Link
US (2) US8414904B2 (enExample)
EP (2) EP1985298A1 (enExample)
JP (1) JP5452472B2 (enExample)
CN (1) CN101674804B (enExample)
AU (1) AU2008240964B2 (enExample)
CA (1) CA2683672C (enExample)
ES (1) ES2425593T3 (enExample)
MX (1) MX2009011391A (enExample)
NZ (1) NZ579954A (enExample)
RU (1) RU2460516C2 (enExample)
WO (1) WO2008128779A1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985298A1 (en) * 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
JP2009040727A (ja) * 2007-08-09 2009-02-26 Towa Yakuhin Kk ラタノプロストを有効成分とする安定な点眼液剤
FR2934955B1 (fr) * 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
FR2938757B1 (fr) * 2008-11-27 2010-12-31 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation cosmetique ou dermatologique
EP2228058A1 (en) * 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
DE102009021372A1 (de) * 2009-05-14 2010-11-18 Ursapharm Arzneimittel Gmbh Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung
US9480645B2 (en) * 2009-06-02 2016-11-01 Abbott Medical Optics Inc. Omega-3 oil containing ophthalmic emulsions
AU2014250656B2 (en) * 2009-06-02 2016-05-05 Johnson & Johnson Surgical Vision, Inc. Omega-3 oil containing ophthalmic emulsions
US20100303915A1 (en) * 2009-06-02 2010-12-02 Abbott Medical Optics Inc. Therapeutic opthalmic emulsions
US20100305046A1 (en) 2009-06-02 2010-12-02 Abbott Medical Optics Inc. Stable cyclosporine containing ophthalmic emulsion for treating dry eyes
NZ716349A (en) * 2009-11-09 2017-07-28 Allergan Inc Compositions and methods for stimulating hair growth
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
WO2012021107A2 (en) 2010-08-12 2012-02-16 Nanyang Technological University A liposomal formulation for ocular drug delivery
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
US9278132B2 (en) * 2012-02-13 2016-03-08 Bausch & Lomb Incorporated Ophthalmic pharmaceutical compositions and methods of making and using same
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
KR20170120161A (ko) * 2015-03-05 2017-10-30 알러간, 인코포레이티드 안과용 약물 전달을 위한 자가-유화 약물 전달 시스템(sedds)
KR101848124B1 (ko) * 2015-03-31 2018-04-11 단국대학교 천안캠퍼스 산학협력단 타크로리무스의 경구용 과포화성 마이크로에멀젼 조성물
CN105748415B (zh) * 2016-03-18 2019-05-07 上海方予健康医药科技有限公司 一种前列地尔冻干微乳组合物及其制备方法
KR101770324B1 (ko) 2016-11-09 2017-08-22 주식회사태준제약 안압 강하용 점안 조성물
FR3064002B1 (fr) 2017-03-14 2021-07-02 Prevor Int Melange liquide pour nettoyer les deversements de peinture, vernis, colorant et/ou lasure
JP7569336B2 (ja) 2019-06-11 2024-10-17 サイファイ エス．ピー．エー． マイクロエマルション組成物
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
BR112022005354A2 (pt) * 2019-09-23 2022-08-23 Dds Res Inc Composições de vesícula lipídica com agentes potencializadores de penetração
CA3182954A1 (en) * 2020-05-13 2021-11-18 Follicle Pharma Ltd Compositions for delivery of bioactive agents into hair follicles
EP3919047A1 (en) * 2020-06-03 2021-12-08 AZAD Pharma AG Microemulsion for the treatment of dry eye syndrome
WO2022138842A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物
CA3213099A1 (en) 2021-03-24 2022-09-29 Robert A. Love Peptides and methods for reducing skin pigmentation
ES2944784B8 (es) 2021-12-23 2026-04-21 Univ Madrid Complutense Microemulsión oftálmica, procedimiento de obtención y uso dado a la misma
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608073A (en) * 1968-07-16 1971-09-21 Barnes Hind Pharm Inc Emulsion of pilocarpine for ophthalmic use
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
US5171566A (en) * 1986-05-16 1992-12-15 The Green Cross Corporation Flurbiprofen derivative ophthalmic preparation
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
CA2031469A1 (en) 1989-12-28 1991-06-29 Larry A. Wheeler Use of inclusion complexes of prostaglandins with cyclodextrins in the treatment of ocular hypertension
EP0458588B1 (en) 1990-05-22 1994-11-30 R-Tech Ueno Ltd. Treatment of ocular hypertension with a synergistic combination for ocular administration
IL98747A0 (en) 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
SE518823C2 (sv) 1994-07-12 2002-11-26 Karlshamns Lipidteknik Ab Olja-i-vatten-emulsioner
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5827835A (en) * 1994-08-30 1998-10-27 Alcon Laboratories, Inc. Thermally-gelling emulsions
US6294563B1 (en) * 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
SE9503143D0 (sv) 1995-09-12 1995-09-12 Astra Ab New preparation
US6770675B2 (en) * 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
US6417228B1 (en) * 1998-11-02 2002-07-09 Alcon Manufacturing, Ltd.. 13-Aza prostaglandins for the treatment of glaucoma and ocular hypertension
PT1321144E (pt) * 2000-09-13 2011-03-10 Santen Pharmaceutical Co Ltd Colírio
EP1209834B1 (en) * 2000-11-28 2017-11-08 Kabushiki Kaisha Toshiba Ring interconnection network system, node equipment, network management equipment, and path setting method
US20030215471A1 (en) * 2001-01-31 2003-11-20 Wilmott James M. Surfactant free topical compositions and method for rapid preparation thereof
WO2002096367A2 (en) * 2001-05-30 2002-12-05 Targesome, Inc. Targeted multivalent macromolecules
KR100446960B1 (ko) * 2001-12-04 2004-09-01 김종국 프로스타글란딘 ｅ1을 포함하는 온도감응성 에멀젼 외용제조성물
US20040076678A1 (en) * 2002-08-21 2004-04-22 Sucampo Ag Opthalmic solution
EP1532981B1 (en) 2002-08-23 2007-09-26 Santen Pharmaceutical Co., Ltd. Stable eye drops containing latanoprost as the active ingredient
CA2498233C (en) 2002-09-09 2012-08-14 Santen Pharmaceutical Co., Ltd. Clear ophthalmic solution comprising latanoprost as active ingredient
US20040185068A1 (en) 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
EP1655022A4 (en) * 2003-08-01 2010-04-07 Nat Inst Of Advanced Ind Scien MEANS FOR THE TREATMENT OR DIAGNOSIS OF INFLAMMATORY DISEASES WITH A TARGETED LIPOSOM
DE602004023106D1 (de) * 2003-11-07 2009-10-22 Senju Pharma Co Pharmazeutische zusammensetzung mit prostaglandin
US20060182781A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Methods for treating ocular conditions with cyclic lipid contraining microparticles
EP1655021B1 (en) 2004-11-09 2008-10-29 Novagali Pharma SA Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
CA2578176C (en) 2004-11-09 2013-09-24 Novagali Pharma Sa Ophthalmic emulsions containing an immunosuppressive agent
CN101282714B (zh) * 2005-10-10 2012-12-12 诺瓦加利制药公司 包含前列腺素的眼用乳剂
EP1985298A1 (en) * 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins

Also Published As

Publication number Publication date
RU2460516C2 (ru) 2012-09-10
AU2008240964A1 (en) 2008-10-30
US8414904B2 (en) 2013-04-09
CA2683672A1 (en) 2008-10-30
NZ579954A (en) 2011-04-29
US20130195936A1 (en) 2013-08-01
JP5452472B2 (ja) 2014-03-26
CN101674804A (zh) 2010-03-17
US20100112016A1 (en) 2010-05-06
WO2008128779A1 (en) 2008-10-30
ES2425593T3 (es) 2013-10-16
EP2136782B1 (en) 2013-06-05
JP2010524992A (ja) 2010-07-22
HK1133598A1 (en) 2010-04-01
AU2008240964B2 (en) 2013-03-07
CN101674804B (zh) 2013-02-13
EP2136782A1 (en) 2009-12-30
CA2683672C (en) 2015-10-06
EP1985298A1 (en) 2008-10-29
RU2009143324A (ru) 2011-05-27

Similar Documents

Publication Publication Date Title
ECSP12012037A (es) Composiciones oftálmicas no irritantes de iodopovidona
PL2178504T3 (pl) Roztwór oczny na bazie prostagladyn bez środka konserwującego
BR112017022021A2 (pt) aplicação de agente anticaspa solúvel em tensoativo
CL2019000586A1 (es) Composiciones de toxinas clostridiales no proteicas.
WO2014081950A3 (en) Fabric care compositions comprising emulsions
WO2011134944A3 (en) Low-oil pharmaceutical emulsion compositions comprising progestogen
CL2009000624A1 (es) Composicion farmaceutica oftalmica que comprende un vehiculo que incluye agua, un agente terapeutico que es una prostaglandina, un compuesto de amonio cuaternario polimerico y 0,01-04% p/v de un surfafactante que es aceite vegetal etoxilado y/o hidrogenado, libre de cloruro de benzxalconio; util para tratar glaucoma
EP2638903A4 (en) SUPPRESSOR FOR INCREASING THE BLOOD SUGAR MIRROR
MA32638B1 (fr) Procede de lutte contre la degradation d'ingredients actifs chimiques agricoles
NZ603345A (en) Stabilized ophthalmic galactomannan formulations
MX370903B (es) Composiciones de ácido percarboxílico estables y sus usos.
CO6280437A2 (es) Una composicion de emulsion de aceite en agua que tiene una fase de agua y nua fase de aceite comprendiendo un modificador polimerico y un compuesto activo agricolamente
EP4302734A3 (en) Ocular delivery systems and methods
AR092523A1 (es) Proceso para fabricar un agente de estructuracion cristalino
PH12013502550A1 (en) Controlled release peptide formulations
BR112015009048A2 (pt) composições pesticidas agrícolas
AR049113A1 (es) Un metodo para preparar una solucion oftalmica y solucion oftalmica obtenida de un agente activo como latanoprost
CR11747A (es) Microemulsion mejorada que tiene un amplio rango de aplicacion
MX2019003611A (es) Formulaciones novedosas.
MX349169B (es) Composiciones farmaceuticas oftalmicas y metodos para elaborar y usar las mismas.
IN2014DN10574A (enExample)
AR054118A1 (es) Amidas de acido pirazolcarboxilico
WO2010107482A3 (en) Germicidal composition
IN2014MN00929A (enExample)
AR108368A1 (es) Preparación y dispersión de formulaciones de emulsión estable

Legal Events

Date Code Title Description
FG Grant or registration